| scholarly article | Q13442814 |
| P356 | DOI | 10.1253/CIRCJ.71.186 |
| P698 | PubMed publication ID | 17251664 |
| P2093 | author name string | Kazuo Kimura | |
| Satoshi Umemura | |||
| Kengo Tsukahara | |||
| Kiyoshi Hibi | |||
| Masami Kosuge | |||
| Noriaki Iwahashi | |||
| Toshiaki Ebina | |||
| Ikuyoshi Kusama | |||
| Toshiyuki Ishikawa | |||
| Hideto Yano | |||
| Hiroyuki Ozaki | |||
| Jyun Okuda | |||
| Tastuya Nakati | |||
| P433 | issue | 2 | |
| P921 | main subject | acute coronary syndrome | Q266018 |
| P304 | page(s) | 186-190 | |
| P577 | publication date | 2007-02-01 | |
| P1433 | published in | Circulation Journal | Q1955928 |
| P1476 | title | Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes | |
| P478 | volume | 71 |
| Q33655192 | A pro-atherogenic HDL profile in coronary heart disease patients: an iTRAQ labelling-based proteomic approach |
| Q37156874 | Acute phase reactants as novel predictors of cardiovascular disease |
| Q35153889 | Adipose tissue-derived human serum amyloid a does not affect atherosclerotic lesion area in hSAA1+/-/ApoE-/- mice |
| Q38626596 | An integrated approach to coronary heart disease diagnosis and clinical management |
| Q88622102 | Biochemical markers of cardiac dysfunction in children with obstructive sleep apnoea (OSA) |
| Q35123578 | Comparison of serum amyloid A protein and C-reactive protein levels as inflammatory markers in periodontitis |
| Q42867694 | Comparison of the Effects of Enoxaparin and Heparin on Inflammatory Biomarkers in Patients with ST-segment Elevated Myocardial Infarction: A prospective Open Label Pilot Clinical Trial |
| Q35019922 | Consolidated and emerging inflammatory markers in coronary artery disease |
| Q36771716 | Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation |
| Q28302517 | Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice |
| Q36907478 | Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker |
| Q26774903 | Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics |
| Q37115819 | Emerging families of biomarkers for coronary artery disease: inflammatory mediators |
| Q33911023 | Establishment of a transgenic mouse model specifically expressing human serum amyloid A in adipose tissue |
| Q90760267 | Evolution of Biomarkers of Atherogenic Risk in Liver Transplantation Recipients |
| Q34588071 | Increased concentrations of Serum amyloid A in dogs with sepsis caused by pyometra |
| Q34089724 | Inflammation, a Link between Obesity and Cardiovascular Disease |
| Q37698323 | Inflammatory biomarkers and coronary heart disease: from bench to bedside and back. |
| Q35992029 | Leukocyte chemoattractant receptor FPR2 may accelerate atherogenesis |
| Q89433919 | Serum Amyloid A Is an Exchangeable Apolipoprotein |
| Q47287451 | Serum Amyloid A3 is a High-Density Lipoprotein-associated Acute Phase Protein |
| Q34697924 | Serum amyloid A as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis |
| Q36962846 | Serum amyloid A is found on ApoB-containing lipoproteins in obese humans with diabetes |
| Q44984044 | Serum amyloid A protein and hypoxic ischemic encephalopathy in the newborn |
| Q84590562 | Serum amyloid-A levels in neonatal necrotizing enterocolitis |
| Q37041836 | Serum high-sensitivity C-reactive protein, amyloid associated protein and N-terminal proBNP levels do not predict reversible myocardial ischaemia |
| Q36216932 | Serum proteomics and disease-specific biomarkers of patients with advanced gastric cancer |
| Q37420498 | Time-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation. |
Search more.